Viewing Study NCT05634967

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:53 AM

Ignite Modification Date: 2025-12-25 @ 11:08 PM

Study NCT ID: NCT05634967

Status: RECRUITING

Last Update Posted: 2025-01-14

First Post: 2022-11-22

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Kesimpta (Ofatumumab) Pregnancy Registry

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module